V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006008 | 10003850 | 1.71 | null | null | 2016-07-08 | 2016-07-30 | Oxaliplatin + Modified de Gramont | 02 | N | 10309254 | OXALIPLATIN + MDG |
| 10006009 | 10003851 | null | null | Palliative (P) | 2019-07-04 | 2019-07-22 | Irinotecan + De Gramont | 2 | N | 10309458 | IRINOTECAN + MDG |
| 10006010 | 10003852 | 0 | 62 | Neo-adjuvant (N) | 2017-01-05 | 2017-01-05 | Irinotecan + Modified De Gramont | N | N | 10309472 | IRINOTECAN + MDG |
| 10006011 | 10003853 | 1.56 | 77.4 | Adjuvant (A) | null | 2015-06-10 | Rituximab | 02 | N | 10309522 | RITUXIMAB |
| 10006012 | 10003854 | 1.78 | 86 | Palliative (P) | 2018-09-27 | 2018-09-27 | CHOP R - 21 days | N | N | 10309941 | CHOP R |
| 10006013 | 10003854 | 1.7 | 85 | Adjuvant (A) | 2017-07-12 | 2018-02-14 | CHOP R - 21 days | N | N | 10309941 | CHOP R |
| 10006014 | 10003855 | 1.73 | 121.8 | Curative (C) | 2015-09-09 | 2015-09-21 | CHOP R | 2 | N | 10310179 | CHOP R |
| 10006015 | 10003856 | 1.69 | 75.2 | Palliative (P) | 2016-08-13 | 2016-08-14 | Rituximab | 2 | N | 10310179 | RITUXIMAB |
| 10006016 | 10003857 | null | 71 | Adjuvant (A) | 2016-08-09 | 2016-08-22 | Docetaxel 100mg/m2 (21 day) | 2 | N | 10310406 | DOCETAXEL |
| 10006017 | 10003859 | 1.67 | 100.3 | Palliative (P) | 2017-12-24 | 2018-01-03 | Paclitaxel 7 day | N | N | 10310778 | PACLITAXEL |
| 10006018 | 10003860 | 1.46 | 70.3 | Curative (C) | 2018-06-28 | 2018-07-18 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 10310862 | PACLITAXEL |
| 10006019 | 10003861 | 1.79 | 77.9 | Palliative (P) | 2016-08-13 | 2016-09-09 | Docetaxel 100mg/m2 (21 day) | N | N | 10311023 | DOCETAXEL |
| 10006020 | 10003862 | 1.65 | 104 | Palliative (P) | 2018-04-11 | 2018-04-16 | PEMBROLIZUMAB | 02 | N | 10311128 | PEMBROLIZUMAB |
| 10006021 | 10003863 | 1.58 | 104 | Palliative (P) | 2019-03-02 | 2019-03-02 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10311643 | PACLITAXEL |
| 10006022 | 10003864 | 1.85 | 92.6 | Curative (C) | 2017-09-22 | 2018-02-05 | PEMBROLIZUMAB | 02 | N | 10312002 | PEMBROLIZUMAB |
| 10006023 | 10007063 | 1.5 | null | Palliative (P) | 2018-03-14 | 2018-04-07 | CHOP R | N | N | 10312083 | CHOP R |
| 10006024 | 10003865 | 1.72 | 53 | Curative (C) | 2018-12-16 | 2019-01-10 | CHOP R | 2 | N | 10312102 | CHOP R |
| 10006025 | 10003865 | 1.74 | 66 | Disease modification (D) | 2016-10-29 | 2016-11-26 | Oxaliplatin + Modified de Gramont | 02 | N | 10312102 | OXALIPLATIN + MDG |
| 10006026 | 10003866 | 1.68 | null | Palliative (P) | 2014-03-02 | 2014-03-21 | Docetaxel 100mg/m2 (21 day) | N | null | 10316497 | DOCETAXEL |
| 10006027 | 10003866 | 1.67 | 92.6 | Palliative (P) | 2013-04-08 | 2014-04-03 | Trastuzumab Subcutaneous | N | N | 10316497 | TRASTUZUMAB |
| 10006028 | 10003868 | 1.69 | 70.3 | Palliative (P) | 2018-03-17 | 2018-07-28 | Trastuzumab Subcutaneous | N | N | 10320741 | TRASTUZUMAB |
| 10006029 | 10003869 | null | 45.5 | Palliative (P) | null | 2016-05-09 | TRASTUZUMAB | 2 | N | 10320741 | TRASTUZUMAB |
| 10006030 | 10003870 | 1.72 | 77.4 | Palliative (P) | 2014-06-25 | 2014-06-25 | TRASTUZUMAB | N | null | 10321962 | TRASTUZUMAB |
| 10006031 | 10003870 | 1.73 | 76 | Disease modification (D) | 2018-04-18 | 2018-04-24 | Docetaxel | null | null | 10321962 | DOCETAXEL |
| 10006032 | 10003871 | 1.8 | 73.6 | Disease modification (D) | 2015-04-08 | 2015-04-18 | PEMBROLIZUMAB | N | null | 10324762 | PEMBROLIZUMAB |
| 10006033 | 10003873 | 0 | 77.9 | Curative (C) | 2018-11-02 | 2018-11-02 | Rituximab | N | N | 10330063 | RITUXIMAB |
| 10006034 | 10007068 | 1.69 | null | Adjuvant (A) | 2014-08-16 | 2014-08-25 | CHOP R | N | N | 10330240 | CHOP R |
| 10006035 | 10003874 | 1.86 | 94 | Palliative (P) | 2018-02-10 | 2018-02-12 | PEMBROLIZUMAB | N | N | 10330756 | PEMBROLIZUMAB |
| 10006036 | 10003874 | null | 70.3 | Palliative (P) | 2018-03-19 | 2018-03-23 | Trastuzumab 21 day maintenance | 02 | N | 10330756 | TRASTUZUMAB |
| 10006037 | 10008374 | 1.75 | null | Curative (C) | 2013-07-01 | 2013-08-13 | CAPECITABINE + OXALIPLATIN | N | Y | 10331368 | CAPECITABINE + OXALIPLATIN |
| 10006038 | 10003876 | 1.68 | 61.4 | Disease modification (D) | 2016-08-03 | 2016-08-10 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10334435 | RITUXIMAB |
| 10006039 | 10003877 | 1.62 | 63.4 | Disease modification (D) | null | 2016-09-18 | Docetaxel 100mg/m2 (21 day) | 2 | N | 10334674 | DOCETAXEL |
| 10006040 | 10003877 | null | 89.9 | Curative (C) | 2017-03-22 | 2017-03-29 | Capecitabine + Oxaliplatin 21day | 01 | N | 10334674 | CAPECITABINE + OXALIPLATIN |
| 10006041 | 10003877 | 1.71 | 72 | Neo-adjuvant (N) | 2018-05-18 | 2018-05-18 | Capecitabine + Oxaliplatin 21day | N | N | 10334674 | CAPECITABINE + OXALIPLATIN |
| 10006042 | 10003879 | 1.8 | 78 | Palliative (P) | null | 2016-12-03 | Paclitaxel 7 day | N | null | 10339536 | PACLITAXEL |
| 10006043 | 10003879 | null | 0 | Curative (C) | 2016-07-31 | 2016-08-04 | Rituximab | N | N | 10339536 | RITUXIMAB |
| 10006044 | 10003880 | 1.84 | 67.4 | Palliative (P) | 2019-02-25 | 2019-02-25 | Docetaxel 100mg/m2 (21 day) | N | N | 10340935 | DOCETAXEL |
| 10006045 | 10003880 | 1.84 | 85.5 | Palliative (P) | 2018-07-04 | 2018-07-10 | Paclitaxel (2 or 3 weekly) | 02 | N | 10340935 | PACLITAXEL |
| 10006046 | 10003880 | 1.71 | null | Neo-adjuvant (N) | 2015-08-10 | 2015-08-10 | Docetaxel 100mg/m2 (21 day) | N | N | 10340935 | DOCETAXEL |
| 10006047 | 10003880 | 1.66 | 57.3 | Palliative (P) | 2016-10-31 | 2016-11-21 | CHOP R - 21 days | 2 | N | 10340935 | CHOP R |
| 10006048 | 10003883 | 1.7 | 73.7 | Palliative (P) | 2019-02-27 | 2019-03-08 | Capecitabine + Oxaliplatin 21day | N | N | 10341698 | CAPECITABINE + OXALIPLATIN |
| 10006049 | 10003883 | 1.85 | null | null | 2017-08-03 | 2017-08-06 | PACLITAXEL | N | N | 10341698 | PACLITAXEL |
| 10006050 | 10007075 | 1.75 | 67.8 | Palliative (P) | 2013-11-29 | 2013-12-27 | Docetaxel | 01 | N | 10342709 | DOCETAXEL |
| 10006051 | 10007075 | 1.57 | 66.3 | Adjuvant (A) | 2015-11-03 | 2015-11-15 | FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 10342709 | OXALIPLATIN + MDG |
| 10006052 | 10003885 | 1.8 | 72.7 | Disease modification (D) | null | 2017-04-02 | PACLITAXEL | N | N | 10343107 | PACLITAXEL |
| 10006053 | 10003886 | 1.71 | null | null | 2016-08-04 | 2017-12-24 | CHOP R - 21 days | 02 | N | 10343133 | CHOP R |
| 10006054 | 10003886 | 0 | null | Curative (C) | 2013-12-18 | 2014-01-06 | Capecitabine + Oxaliplatin 14day | N | null | 10343133 | CAPECITABINE + OXALIPLATIN |
| 10006055 | 10003886 | 1.64 | 100 | Palliative (P) | 2018-09-01 | 2018-09-23 | Rituximab (Maintenance) | N | N | 10343133 | RITUXIMAB |
| 10006056 | 10003887 | null | null | Palliative (P) | 2018-08-01 | 2018-08-03 | PEMBROLIZUMAB | N | N | 10343780 | PEMBROLIZUMAB |
| 10006057 | 10003888 | 1.67 | 83.4 | Palliative (P) | 2015-10-02 | 2015-10-03 | CHOP R | N | N | 10344281 | CHOP R |